ecopipam has been researched along with Obesity in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Astrup, A; Greenway, FL; Kwan, R; Lachowicz, J; Ling, W; Pedicone, L; Strader, CD | 1 |
1 trial(s) available for ecopipam and Obesity
Article | Year |
---|---|
Randomized controlled trials of the D1/D5 antagonist ecopipam for weight loss in obese subjects.
Topics: Adolescent; Adult; Aged; Benzazepines; Body Mass Index; Diabetes Mellitus, Type 2; Dopamine Antagonists; Double-Blind Method; Female; Humans; Male; Middle Aged; Obesity; Patient Selection; Placebos; Weight Loss | 2007 |